Paper41596404
Thrombospondin 1-CD47 Signalling Modulates Vascular Smooth Muscle Cell Senescence in Chronic Kidney Disease.
Trinh K and 5 others. Int J Mol Sci, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Thrombospondin 1-CD47 Signalling Modulates Vascular Smooth Muscle Cell Senescence in Chronic Kidney Disease. Papers, record 41596404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41596404
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Thrombospondin 1-CD47 Signalling Modulates Vascular Smooth Muscle Cell Senescence in Chronic Kidney Disease.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD47 Antigen | Major topic |
| Thrombospondin 1 | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Cellular Senescence | Major topic |
| Muscle, Smooth, Vascular | Major topic |
| Signal Transduction | Major topic |
| Myocytes, Smooth Muscle | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Mice, Knockout | |
| Male | |
| Cell Proliferation | |
| Aorta | |
| Indican |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GNT200799 | NHMRC | PubMed | ||
| 106035 | National Heart Foundation of Australia | PubMed | ||
| WMRF | Westmead Medical Research Foundation | PubMed |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36563690 | Retention of ERK in the cytoplasm mediates the pluripotency of embryonic stem cells. | Stem Cell Reports | 2023 | https://conductscience.org/library/papers/36563690 | PubMed |
| 2 | 31109451 | Vascular smooth muscle cell senescence and age-related diseases: State of the art. | Biochim Biophys Acta Mol Basis Dis | 2019 | https://conductscience.org/library/papers/31109451 | PubMed |
| 3 | 9271435 | Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. | Mol Cell Biol | 1997 | https://conductscience.org/library/papers/9271435 | PubMed |
| 4 | 28778947 | Disturbed Flow Promotes Arterial Stiffening Through Thrombospondin-1. | Circulation | 2017 | https://conductscience.org/library/papers/28778947 | PubMed |
| 5 | 34501251 | Arterial Remodelling in Chronic Kidney Disease: Impact of Uraemic Toxins and New Pharmacological Approaches. | J Clin Med | 2021 | https://conductscience.org/library/papers/34501251 | PubMed |
| 6 | 17038480 | Mitogen activated protein kinase inhibitors: where are we now and where are we going? | Ann Rheum Dis | 2006 | https://conductscience.org/library/papers/17038480 | PubMed |
| 7 | 40887468 | Arterial stiffness and vascular aging: mechanisms, prevention, and therapy. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40887468 | PubMed |
| 8 | 22215724 | Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1. | Cardiovasc Res | 2012 | https://conductscience.org/library/papers/22215724 | PubMed |
| 9 | 15890262 | Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor. | Matrix Biol | 2005 | https://conductscience.org/library/papers/15890262 | PubMed |
| 10 | 22326498 | Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-κB, p53, ERK, and JNK in proximal tubular cells. | Life Sci | 2012 | https://conductscience.org/library/papers/22326498 | PubMed |
| 11 | 21567467 | p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease. | J Clin Lab Anal | 2011 | https://conductscience.org/library/papers/21567467 | PubMed |
| 12 | 33920030 | Thrombospondin-1 CD47 Signalling: From Mechanisms to Medicine. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33920030 | PubMed |
| 13 | 37053275 | Endothelial Cell Dysfunction and Increased Cardiovascular Risk in Patients With Chronic Kidney Disease. | Circ Res | 2023 | https://conductscience.org/library/papers/37053275 | PubMed |
| 14 | 32366943 | Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis. | Lab Invest | 2020 | https://conductscience.org/library/papers/32366943 | PubMed |
| 15 | 24599232 | The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease. | Toxins (Basel) | 2014 | https://conductscience.org/library/papers/24599232 | PubMed |
| 16 | 26168731 | Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. | Biochem Biophys Res Commun | 2015 | https://conductscience.org/library/papers/26168731 | PubMed |
| 17 | 16835222 | CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16835222 | PubMed |
| 18 | 20937831 | Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20937831 | PubMed |
| 19 | 29543732 | Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated. | Toxins (Basel) | 2018 | https://conductscience.org/library/papers/29543732 | PubMed |
| 20 | 27742621 | TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction. | Cardiovasc Res | 2017 | https://conductscience.org/library/papers/27742621 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42783079 | Cell-Surface Signatures and Targets of Modulated Vascular Smooth Muscle Cells in Atherosclerosis: From State Identification to Precision Intervention. | J Cardiovasc Dev Dis | 2026 | https://conductscience.org/library/papers/42783079 | PubMed |
| 42353310 | Decoding the Gut-Fat-Heart Axis: From Molecular Communication Networks to Clinical Translation Strategies. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353310 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41596404
GET https://conductscience.org/api/papers/v1/41596404/references?page=2